Rapacuronium. Introduction.
Bevan
David R
DR
UBC Department of Anesthesia, Vancouver, British Columbia, Canada.
D017277:Drug Approval; D006801:Humans; D003473:Neuromuscular Nondepolarizing Agents / Q000493:pharmacokinetics / Q000494:pharmacology*; D014481:United States; D014486:United States Food and Drug Administration; D014673:Vecuronium Bromide / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000494:pharmacology
D003473:Neuromuscular Nondepolarizing Agents; D014673:Vecuronium Bromide; C082938:rapacuronium